Clostridium difficile is a significant source of infectious disease death in the United States, and C. difficile infection can be difficult to treat. Many researchers are focusing on new therapies for this major health problem, including clinical use of fecal microbiota transplantation. Dietary manipulations are another avenue of study. Researchers at the Stanford University School of Medicine recently published a paper in this vein entitled “Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model” in the journal Nature Microbiology.
Read more at: Taconic Insights